Syneos Health has entered a multi-year strategic agreement with Microsoft. Using Microsoft Azure services, Syneos Health has developed an advanced analytics platform designed to enable agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and commercial programs worldwide.
The agreement includes collaboration with Microsoft Research and leverages developments from OpenAI. Syneos Health will deliver technology and data solutions with Microsoft that aim to accelerate clinical development and elevate commercial performance for biopharma customers.
